Valerie Schwitzgebel (@vschwitzgebel) 's Twitter Profile
Valerie Schwitzgebel

@vschwitzgebel

Professor University of Geneva, Head Pediatric Endocrinology & Diabetes

ID: 1229861426493349893

calendar_today18-02-2020 20:13:44

49 Tweet

77 Followers

232 Following

Pål R. Njølstad (@palrnjolstad) 's Twitter Profile Photo

Finally, the paper is live in The Lancet Reg Health-Europe An HNF1A variant in 7% of #Greenlanders with #diabetes Thanks for super collaborations NNF Center for Basic Metabolic Research (CBMR) led by prof Torben Hansen and many others; and support by @mohnfoundation Haukeland @medofak_uib doi.org/10.1016/j.lane…

Mark Evans (@mevanscambridge) 's Twitter Profile Photo

Wow- World’s first type 1 diabetes disease-modifying drug approved in the US - JDRF, the type 1 diabetes charity jdrf.org.uk/news/worlds-fi…

Beyond Type 1 (@beyondtype1) 's Twitter Profile Photo

🚨 BREAKING: The FDA has approved teplizumab, an immune therapy drug shown to delay the onset of type 1 diabetes. Read our full coverage here. beyondtype1.org/teplizumab-fda…

BSPED (@britsped) 's Twitter Profile Photo

Tepluzimab, an anti-CD3 antibody, which has been shown to slow the onset of type 1 diabetes has now been approved by the FDA for children and adults with preclinical type 1 diabetes. It is not currently licensed in the UK and will need to be approved before it becomes available.

ISPAD (@ispad_org) 's Twitter Profile Photo

ISPAD's November Newsletter is now available on the website! Click here to access to our latest news, a summary from ISPAD 2022, a message from our new ISPAD's president, David Maahs and more: loom.ly/oIkvplI #ISPADNews #ISPAD

ISPAD's November Newsletter is now available on the website! 

Click here to access to our latest news, a summary from ISPAD 2022, a message from our new ISPAD's president, David Maahs and more: loom.ly/oIkvplI

#ISPADNews #ISPAD
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

"Here we are 100 years later making use of these chemistries in ways that we hope will benefit human health." In her #NobelPrize lecture Carolyn Bertozzi spoke about how her work builds on curiosity-driven research, and how important that type of research can be for our futures.

Daniel J Drucker (@danieljdrucker) 's Twitter Profile Photo

Finally, we know how #metformin works, in the gut to increase basolateral intestinal glucose uptake (BIGU) and via gut liver cross talk to reduce hepatic glucose production PNASNews #diabetes pnas.org/doi/10.1073/pn…

Timo Otonkoski (@otonkoskit) 's Twitter Profile Photo

Very happy to see our long-term project on the functional characterization of an RFX6 mutation enriched in Finns published in Diabetologia. Superb work by Hazem Ibrahim. Read here: rdcu.be/dHX38

Dr Kirstie Bell (@drkirstiebell) 's Twitter Profile Photo

The new face of T1D: The condition starts silently (Stage 1 & 2) before progressing to hyperglycaemia, symptoms & insulin (Stage 3 T1D) - Prof Chantal Mathieu "Our generation will see the end of type 1 diabetes... preventing beta-cell destruction" #24ADC

The new face of T1D: The condition starts silently (Stage 1 & 2) before progressing to hyperglycaemia, symptoms & insulin (Stage 3 T1D) - Prof Chantal Mathieu 

"Our generation will see the end of type 1 diabetes... preventing beta-cell destruction" 

#24ADC
Valerie Schwitzgebel (@vschwitzgebel) 's Twitter Profile Photo

🧠🍽️ New in @NeuronCellPress: "The neurobiology of overeating" — Stuber, Schwitzgebel & Lüscher explore how brain circuits of hunger, reward & addiction interact to drive overeating and obesity. A roadmap for future treatments. doi.org/10.1016/j.neur… #Obesity #Food #GLP1